Microbot Medical Inc buy The Goldman Sachs Group, Inc.
Start price
24.01.24
/
50%
€1.17
Target price
24.01.25
€5.51
Performance (%)
-25.77%
Price
30.04.24
€0.87
Summary
This prediction is currently active. The prediction for Microbot Medical Inc disappoints with a performance of -25.77%. This prediction currently runs until 24.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Microbot Medical Inc | 6.958% | 6.958% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Microbot Medical Inc diskutieren
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat